BioCentury
ARTICLE | Clinical News

XOMA Corp. regulatory update

May 8, 1995 7:00 AM UTC

XOMA (Berkeley, Calif.) received a U.S. patent and a notice of allowance for a European patent, both covering its bactericidal/permeability-increasing protein (BPI). U.S. Patent No. 5,420,019 will iss...